Dr. David Zagzag explains when should someone be concerned that forgetfulness may be an indication of cognitive impairment.

Novel treatment for Alzheimer’s disease It has been 30 years since the first drug targeting Alzheimer’s disease (AD) became available on the market. Now, Dr.

According to the American Migraine Association, roughly 39 million people in the United States suffer from migraine attacks, making it one of the country’s most